Concepedia

Mark E. McDonnell

ME

Statistics

Publications

22

Citations

749

H-Index

16

Active since

1992

Affiliations

Fox Chase Chemical Diversity Center(Current)

Springhouse

Johnson & Johnson (United States)

Doylestown Hospital

Rutgers, The State University of New Jersey

Mark E. McDonnell is an author at Fox Chase Chemical Diversity Center specializing in pharmacology, medicinal chemistry, and medicine.

ORCID

Publications per year

1992–2024

22

Publications

22

Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolution

Céline Schalk‐Hihi, Carsten J. Schubert, Richard Alexander et al. · Protein Science · 2011 · 127 citations · Full text

, , +17

Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth

Troy E. Messick, Garry R. Smith, Samantha S. Soldan et al. · Science Translational Medicine · 2019 · 124 citations · Full text

, , +15

Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, with Improved Potency, Safety, and Permeability

William A. Kinney, Mark E. McDonnell, Hua Zhong et al. · ACS Medicinal Chemistry Letters · 2016 · 51 citations · Full text

, , +17

Synthesis and in vitro evaluation of a novel iodinated resiniferatoxin derivative that is an agonist at the human vanilloid VR1 receptor

Mark E. McDonnell, Sui‐Po Zhang, Adrienne E. Dubin et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 40 citations · Full text

, , +7

Orally Active Benzamide Antipsychotic Agents with Affinity for Dopamine D<sub>2</sub>, Serotonin 5-HT<sub>1A</sub>, and Adrenergic α<sub>1</sub>Receptors

Allen B. Reitz, Ellen W. Baxter, Ellen E. Codd et al. · Journal of Medicinal Chemistry · 1998 · 36 citations · Full text

, , +16

1–5 of 22